Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Patten

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Developments in Biologicals|May 24, 2003
The immunogenicity of biopharmaceuticals. Lessons learned and consequences for protein drug developmentP A Patten, H Schellekens
Molecular Diversity|February 1, 1996
Directed evolution studies with combinatorial libraries of T4 lysozyme mutantsP A Patten, T Sonoda, M M Davis
Proceedings of the National Academy of Sciences of the United States of America|February 15, 1993
A genetic approach to the generation of antibodies with enhanced catalytic activitiesS A Lesley, P A Patten, P G Schultz
Current Opinion in Biotechnology|January 13, 1998
Applications of DNA shuffling to pharmaceuticals and vaccinesP A Patten, R J Howard, W P Stemmer
Journal of Molecular Biology|May 2, 1997
Crystal structures of the free and liganded form of an esterolytic catalytic antibodyG J Wedemayer, L H Wang, P A Patten, et al.
Current Opinion in Biotechnology|September 12, 2001
Advances in directed protein evolution by recursive genetic recombination: applications to therapeutic proteinsA L Kurtzman, S Govindarajan, K Vahle, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 5, 1995
Expression studies of catalytic antibodiesH D Ulrich, P A Patten, P L Yang, et al.
Science (New York, N.Y.)|June 13, 1997
Structural insights into the evolution of an antibody combining siteG J Wedemayer, P A Patten, L H Wang, et al.
Nature|February 18, 1988
The adult T-cell receptor delta-chain is diverse and distinct from that of fetal thymocytesJ F Elliott, E P Rock, P A Patten, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1993
Transfer of putative complementarity-determining region loops of T cell receptor V domains confers toxin reactivity but not peptide/MHC specificityP A Patten, E P Rock, T Sonoda, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Developments in Biologicals|May 24, 2003
The immunogenicity of biopharmaceuticals. Lessons learned and consequences for protein drug developmentP A Patten, H Schellekens
Molecular Diversity|February 1, 1996
Directed evolution studies with combinatorial libraries of T4 lysozyme mutantsP A Patten, T Sonoda, M M Davis
Proceedings of the National Academy of Sciences of the United States of America|February 15, 1993
A genetic approach to the generation of antibodies with enhanced catalytic activitiesS A Lesley, P A Patten, P G Schultz
Current Opinion in Biotechnology|January 13, 1998
Applications of DNA shuffling to pharmaceuticals and vaccinesP A Patten, R J Howard, W P Stemmer
Journal of Molecular Biology|May 2, 1997
Crystal structures of the free and liganded form of an esterolytic catalytic antibodyG J Wedemayer, L H Wang, P A Patten, et al.
Current Opinion in Biotechnology|September 12, 2001
Advances in directed protein evolution by recursive genetic recombination: applications to therapeutic proteinsA L Kurtzman, S Govindarajan, K Vahle, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 5, 1995
Expression studies of catalytic antibodiesH D Ulrich, P A Patten, P L Yang, et al.
Science (New York, N.Y.)|June 13, 1997
Structural insights into the evolution of an antibody combining siteG J Wedemayer, P A Patten, L H Wang, et al.
Nature|February 18, 1988
The adult T-cell receptor delta-chain is diverse and distinct from that of fetal thymocytesJ F Elliott, E P Rock, P A Patten, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1993
Transfer of putative complementarity-determining region loops of T cell receptor V domains confers toxin reactivity but not peptide/MHC specificityP A Patten, E P Rock, T Sonoda, et al.
Pageof 2